VXL Life Sciences

This company enables generic portfolio development by offering APIs from its USFDA/EU-GMP API manufacturers, having identified, nurtured and built strong relationships with its principals over the years. In the world of generics with geographically diverse supply chains, the company offers end-to-end support for API sourcing for new product and alternative vendor development projects, with API offerings including peptides, oncology, tinibs, controlled substances, biologicals, steroids, hormones, alkaloids, antibiotics and prostaglandins.